How a Peninsula biotech is going small to change the course of genetic diseases
The company spun out of small-interfering RNA technology centered at City of Hope in Southern California and recently landed a $52 million Series A round.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Ron Leuty Source Type: news